KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

Historic Cash & Current Investments for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $17.2 billion.

  • BioNTech SE's Cash & Current Investments fell 1651.22% to $17.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 billion, marking a year-over-year decrease of 1651.22%. This contributed to the annual value of $17.9 billion for FY2024, which is 1114.78% down from last year.
  • BioNTech SE's Cash & Current Investments amounted to $17.2 billion in Q3 2025, which was down 1651.22% from $15.8 billion recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Cash & Current Investments peaked at $1459786.9 billion during Q1 2021, and registered a low of $1.4 billion during Q3 2021.
  • In the last 5 years, BioNTech SE's Cash & Current Investments had a median value of $15.8 billion in 2025 and averaged $76843.2 billion.
  • As far as peak fluctuations go, BioNTech SE's Cash & Current Investments plummeted by 9999.99% in 2022, and later soared by 71210.88% in 2023.
  • Over the past 5 years, BioNTech SE's Cash & Current Investments (Quarter) stood at $2.4 billion in 2021, then skyrocketed by 504.7% to $14.3 billion in 2022, then soared by 40.67% to $20.2 billion in 2023, then fell by 11.15% to $17.9 billion in 2024, then dropped by 4.15% to $17.2 billion in 2025.
  • Its last three reported values are $17.2 billion in Q3 2025, $15.8 billion for Q2 2025, and $14.4 billion during Q1 2025.